Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2020.082 | A Non-randomized, Clinical Registry of the DynamX Novolimus Eluting Coronary Bioadaptor System in the Treatment of Patients with De Novo Native Coronary Artery Lesions |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2020.080 | A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2018.215 | Electrical Activation Mapping Guided Cardiac Resynchronization Therapy for Nonresponders | Prof. YAN Bryan Ping Yen |
| 2020.154 | BIOFLOW-DAPT: BIOTRONIK – A Prospective, Randomized, Multi-center Study to Assess the SaFety of the Orsiro Mission Stent compared to the ResoLute Onyx Stent in Subjects at High Risk for Bleeding in combination With 1-month Dual AntiPlatelet Therapy |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2010.123 | Cardiovascular Risk Profile & Long-term Clinical Outcomes of Patients with Peripheral Arterial Disease in Hong Kong | Prof. YAN Bryan Ping Yen |
| 2013.082 | Physiologic-Guided Endovascular Revascularization for the Treatment of Atherosclerotic Erectile Dysfunction in Chinese Patients with Suboptimal Response to Pharmacotherapy: A Pilot Study | Prof. YAN Bryan Ping Yen |
| 2013.607 | Dyslipidemia International Study II (DYSIS II) | Dr Yan Bryan Ping Yen |
| 2009.543 | Patients at High Cardiovascular Risk Lack Awareness of the Importance of Risk Factor Modification and the Dire Consequences Associated with Peripheral Artery Disease : A cross sectional cohort study | Prof. YAN Bryan Ping Yen |
| 2009.542 | Impact of unrecognized peripheral arterial disease and additional prognostic value of ankle-brachial index to risk-stratify patients at high cardiovascular risk undergoing coronary angiography or intervention | Prof. YAN Bryan Ping Yen |
| 2016.370 | Patient education, monitoring and support to enhance adherence to dabigatran in patients with non-valvular atrial fibrillation |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.234 | PWH Cardiac Implantable Electronic Devices (CIED) Home Monitoring Registry |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.550 | Validation of Camera-based Measurement of Finger & Facial Photoplethysmographic Signal for Heart Rate and Arrhythmias Detection |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.319 | Investigation on the novel noninvasive sensors and algorithms for validating cuffless continuous blood pressure measurement. |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.531 | Prospective Observational study of Lipid Management in Non-US, Non-Western European Patients Who Have A Recent Acute Coronary Syndrome Event |
Dr. YAN Bryan Ping Yen 甄秉言 |
| 2014.603 | HK-GP AF Screening & Education Program | Prof. YAN Bryan Ping Yen |
| 2016.401 | BIOTRONIKS - Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris - Registry: BIOSOLVE-IV | Dr. YAN Bryan Ping Yen |
| 2016.509 | Hong Kong Percutaneous Coronary Intervention Registry |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.490 | Development of personalized medicine using Prenetics iGenes pharmacogenomic panel to predict individual responses to cardiovascular drugs |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.456 | Diagnostic Accuracy and Incremental Prognostic Value of Exercise MCG in Patients at Risk of Coronary Artery Disease |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.630 | Renal Artery Sympathetic Denervation by Catheter Ablation after Pulmonary Vein Isolation (PVI) for Persistent Atrial Fibrillation |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.266 | Novel Serum Biomarkers Associated with Atherosclerosis-related Vascular Diseases: A Translational Approach | Prof. YAN Bryan Ping Yen |
| 2014.258 | A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting with Acute Coronary Syndrome Treated with Losmapimod Compared to Placebo | Prof. YAN Bryan Ping Yen |
| 2014.381 | Multinational Abluminal Sirolimus Coated BiO-Engineered StenT – The MASCOT Post Marketing Registry | Dr. YAN Bryan Ping Yen |
| 2015.542 | East Asian ALDH2 polymorphism and impact on myocardial infarct size |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2018.068 | A nurse-coordinated integrated care model to support decision-making and self-care in patients with atrial fibrillation: A randomized controlled trial | Prof. YAN Bryan Ping Yen |
| 2014.653 | Changing Pattern of Revascularization for Critical Limb Ischemia towards an Endovascular First Approach in Hong Kong | Prof. YAN Bryan Ping Yen |
| 2017.003 | Implantation of the Venus P-ValveTM in the Pulmonic Position in Patients with Native Outflow Tracts |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.316 | Electrical Activation Mapping Guided Tailor Made Approach for Cardiac Resynchronization Therapy | Prof. YAN Bryan Ping Yen |
| 2015.638 | Defining the athletes heart phenotype: A comparison of male Caucasian and East Asian elite footballers and rugby players |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2014.380 | A pilot study to assess efficacy and safety of a novel Titanium-Nitride coated woven-nitinol Peripheral Arterial Stent | Prof. YAN Bryan Ping Yen |
| 2017.358 | Optical Coherence Tomography evaluation of Bioabsorbable Vascular Scaffold Technique with Magmaris | Prof. YAN Bryan Ping Yen |
| 2016.623 | Pharmacoepidemiology and pharmacoeconomics of oral anticoagulation therapy in Hong Kong | Dr. YAN Bryan Ping Yen |
| 2015.296 | International Survey on Current Status & Future of Drug-Eluting Stents |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.265 | The Effect of CYP2C19 Genetic Variants on Clinical Outcomes in Post-Angioplasty Patients Treated with Clopidogrel |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.302 | ASTRI Wireless ECG Module Public Trial |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.292 | A novel non-invasive radial artery tonometric cardiovascular monitoring device for assessment of vascular aging, subclinical atherosclerosis and cardiovascular risk in the elderly. |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.366 | ACCelerated ThrombolySiS for Post-Thrombotic Syndrome Using the EKOS System |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.291 | Optimal Bioabsorbable Vascular Scaffold Technique for Complex Bifurcation Lesions |
Dr. YAN Bryan Ping Yen 甄秉言 |
| 2015.301 | Effects of Cardiovascular Autonomic Nervous System Activities on BP/ECG/PPG/Respiratory Related Physiological Features, Validation of Improved PTT-based Cuffless BP Estimation with IEEE 1708 Standard, and Measurement of Respiratory Rate with a Novel Method |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.297 | Optical Coherence Tomography evaluation of Very Early eNdothelialization after Dual Therapy Drug-eluting Stent with EPC CaptURE (OCT-VENTURE) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2012.481 | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome | Prof. YAN Bryan Ping Yen |
| 2013.658 | A PHASE 3 DOUNLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDMIA AT RISK OF CARDIOVASCULAR EVENTS | Prof. YAN Bryan Ping Yen |
| 2014.210 | Randomized controlled trial and cost-effectiveness analysis of targeted rapid screening for atrial fibrillation using a handheld single-lead ECG device with automated diagnostics and tailored stroke prevention strategy for screen-detected patients | Prof. YAN Bryan Ping Yen |
| 2013.586 | GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation (Phase II/III) | Prof. YAN Bryan Ping Yen |
| 2012.561 | Novel Treatment of Intermittent Claudication in Patients with Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule | Prof. YAN Bryan Ping Yen |
| 2013.420 | Transcatheter Renal Denervation with an over-the-wire balloon based technology for Patiemts with Resistant Hypertension | Prof. YAN Bryan Ping Yen |
| 2014.332 | A prospective Randomised, open label, blinded endpoint (PROBE) study to Evaluate DUAL antithrombotic therapy with dabigatran etexilate (110mg and 150mg b.i.d.) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0 – 3.0) plus clopidogrel or ticagrelor and aspirin in patients with non valvular atrial fibrillation (NVAF) that have undergone a percutaneous coronary intervention (PCI) with stenting. (RE-DUAL PCI) | Prof. YAN Bryan Ping Yen |
| 2011.178 | A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus | Prof. YAN Bryan Ping Yen |
| 2024.152 | Rationale and design of Dabigatran for Mitral Stenosis Atrial Fibrillation Trial |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.468 | AI-Based Intima-Media Thickness Measurement for Cardiovascular Risk Assessment |
Prof. YAN Bryan Ping Yen 甄秉言 |
Page 17 of 253.